Compare Stocks → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NYSEAMERICAN:ASTCVE:NSENYSE:RMPCVE:RRL Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeASTAsterias Biotherapeutics$0.00$0.00$0.51▼$2.05$111KN/A136,653 shs1,000 shsNSENew Stratus EnergyC$0.57+5.6%C$0.00C$0.21▼C$0.84C$70.16M1.38140,482 shs775,500 shsRMPRice Midstream Partners$1,714.23$0.00$16.68▼$23.00N/AN/A495,689 shsN/ARRLResolute ResourcesC$0.01-33.3%C$0.02C$0.01▼C$0.47C$693K-2.43464,107 shs10,000 shsThe 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceNSENew Stratus Energy-5.26%-12.90%-11.48%+39,415,958.39%+39,415,958.39%RMPRice Midstream Partners0.00%0.00%0.00%0.00%0.00%RRLResolute Resources0.00%-33.33%-33.33%-33.33%-90.00%The A.I. story nobody is telling you (Read ASAP) (Ad)There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...Click here to see Louis' new video for yourself.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationASTAsterias BiotherapeuticsN/AN/AN/AN/AN/AN/AN/AN/ANSENew Stratus EnergyN/AN/AN/AN/AN/AN/AN/AN/ARMPRice Midstream PartnersN/AN/AN/AN/AN/AN/AN/AN/ARRLResolute ResourcesN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceASTAsterias BiotherapeuticsN/AN/AN/AN/ANSENew Stratus Energy3.00BuyN/AN/ARMPRice Midstream PartnersN/AN/AN/AN/ARRLResolute ResourcesN/AN/AN/AN/ACurrent Analyst RatingsLatest RMP, AST, NSE, OXX, and RRL Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails2/26/2024NSENew Stratus EnergyEchelon Wealth PartnersSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingSpeculative Buy(Data available from 4/24/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookASTAsterias BiotherapeuticsN/AN/AN/AN/AN/AN/ANSENew Stratus EnergyC$35.98M1.95N/AN/AC$0.20 per share2.85RMPRice Midstream PartnersN/AN/AN/AN/AN/AN/ARRLResolute ResourcesC$2.18M0.32C$0.00 per share7.14C$0.09 per share0.11Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateASTAsterias BiotherapeuticsN/AN/A0.00∞N/AN/AN/AN/AN/ANSENew Stratus Energy-C$35.46MC$0.202.85∞N/A-98.55%N/AN/A4/29/2024 (Estimated)RMPRice Midstream PartnersN/A$1.98865.77∞N/AN/AN/AN/AN/ARRLResolute Resources-C$2.68M-C$0.03N/A∞N/AN/A-48.46%-15.17%N/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthASTAsterias BiotherapeuticsN/AN/AN/AN/AN/ANSENew Stratus EnergyN/AN/AN/AN/AN/ARMPRice Midstream Partners$1.220.07%N/A61.62%N/ARRLResolute ResourcesN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioASTAsterias BiotherapeuticsN/AN/AN/ANSENew Stratus EnergyN/A6.13N/ARMPRice Midstream PartnersN/AN/AN/ARRLResolute ResourcesN/A1.1810.30OwnershipInstitutional OwnershipCompanyInstitutional OwnershipASTAsterias BiotherapeuticsN/ANSENew Stratus Energy2.40%RMPRice Midstream Partners74.09%RRLResolute Resources2.67%Insider OwnershipCompanyInsider OwnershipASTAsterias BiotherapeuticsN/ANSENew Stratus Energy23.80%RMPRice Midstream PartnersN/ARRLResolute Resources12.18%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableASTAsterias BiotherapeuticsN/A55.66 millionN/ANot OptionableNSENew Stratus EnergyN/A123.09 millionN/AN/ARMPRice Midstream PartnersN/AN/AN/AOptionableRRLResolute ResourcesN/A69.29 millionN/ANot OptionableRMP, AST, NSE, OXX, and RRL HeadlinesSourceHeadlineEvening Wrap: ASX 200 shocked and awed by Israel strike on Iran, gold and oil stocks firmermarketindex.com.au - April 19 at 3:48 AMDecade Resources: Bottom 25 Performing Stocks Year-to-Date on TSX-V (DEC)theglobeandmail.com - April 12 at 11:15 PMClosing Bell: ASX tumbles on Fedspeak; gold and oil jump as Middle East tension escalatesstockhead.com.au - April 12 at 3:12 AMTop 10 at 10: Whopping weapons orders and another record high gold pricestockhead.com.au - April 11 at 10:03 PMResolute Airport, Resolute, Canada [ YRB / CYRB ]prokerala.com - March 6 at 9:01 PMGold prices are soaring: Which ASX gold miner has the highest upside?marketindex.com.au - March 6 at 4:01 PMResolute Resources: Bottom 25 Performing Stocks Year-to-Date on TSX-V (RRL)theglobeandmail.com - February 17 at 12:38 AMAll About Travis Scott's Parents, Wanda and Jacques Websternz.news.yahoo.com - February 6 at 10:38 PMOrd Minnett Remains a Buy on Ramelius Resources Limited (RMLRF)markets.businessinsider.com - January 31 at 3:00 PMRETRANSMISSION: Resolute Resources Ltd Provides Update and Initiates Strategic Reviewfinance.yahoo.com - January 30 at 3:21 PMResolute Resources Ltd Provides Update and Initiates Strategic Reviewfinance.yahoo.com - January 29 at 11:29 PMResolute Resources Ltd Provides Well Updatefinance.yahoo.com - January 12 at 9:16 AMMining Stock News: Resolute Resources (TSXV: RRL) Announces Operational Updateinvestorideas.com - November 13 at 7:45 PMCanadian Investment Regulatory Organization Trade Resumption - RRLca.finance.yahoo.com - November 13 at 2:45 PMResolute Resources Announces Operational Updatefinance.yahoo.com - November 13 at 2:45 PMCanadian Investment Regulatory Organization Trading Halt - RRLfinance.yahoo.com - November 13 at 9:45 AMResolute Resources Ltd.: Resolute Resources Announces Operational Update and Leadership Transitionfinanznachrichten.de - October 31 at 4:17 AMResolute Resources Announces Operational Update and Leadership Transitionfinance.yahoo.com - October 31 at 4:17 AMIs Resolute Resources (CVE:RRL) In A Good Position To Deliver On Growth Plans?finance.yahoo.com - October 24 at 8:04 AMResolute Resources Ltd. Announces Rig Release, Operations Update and 11-24 Well Licensestockhouse.com - September 25 at 1:45 PMTeam Resolute Unveils Evolved Design for Fleet Solid Support Shipsmarinelink.com - September 11 at 11:20 PMResolute Resources Ltd. Announces Rig Mobilization and Spud Datefinance.yahoo.com - September 6 at 9:37 AMValor Names Experienced Executive as ‘Director of Relentless Innovationdallasinnovates.com - July 28 at 9:12 PMPope Condemns 'Relentless' Bombing of Ukrainian Citiesusnews.com - October 16 at 12:40 AMNew MarketBeat Followers Over TimeTop HeadlinesFoot Locker Builds Up Another Head of Steam; Gains ImminentMarch 28, 2024 10:58 AMView Foot Locker Builds Up Another Head of Steam; Gains ImminentLockheed Martin Stock Aims for a Fresh All-Time HighApril 23, 2024 9:59 AMView Lockheed Martin Stock Aims for a Fresh All-Time HighPalantir Technologies: Bearish Sentiment, Bullish Chart SignalsMarch 27, 2024 7:30 AMView Palantir Technologies: Bearish Sentiment, Bullish Chart SignalsDisney Stock Catches 3 Upgrades In a Single WeekMarch 28, 2024 10:27 AMView Disney Stock Catches 3 Upgrades In a Single WeekBreakout Alert: Coinbase's Consolidation Is About To EndApril 12, 2024 9:45 AMView Breakout Alert: Coinbase's Consolidation Is About To EndAll Headlines Company DescriptionsAsterias BiotherapeuticsNYSEAMERICAN:ASTAsterias Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing cell-based therapeutics to treat neurological conditions associated with demyelination, and cellular immunotherapies to treat cancer. Its clinical stage programs include AST-OPC1, an oligodendrocyte progenitor cell population derived from pluripotent stem cells that is in Phase I/IIa clinical trial for spinal cord injuries; AST-VAC2 is a non-patient-specific cancer immunotherapy derived from pluripotent stem cells for the treatment of non-small cell lung cancer; and AST-VAC1, a patient-specific cancer immunotherapy that has completed Phase II clinical trial for the treatment of acute myeloid leukemia. The company was formerly known as BioTime Acquisition Corporation and changed its name to Asterias Biotherapeutics, Inc. in March 2013. Asterias Biotherapeutics, Inc. was founded in 2012 and is headquartered in Fremont, California.New Stratus EnergyCVE:NSENew Stratus Energy Inc. engages in the acquisition, exploration, and development of oil and gas properties principally in Latin America. It has a farm-in agreement to acquire 100% interests in Block VMM-18 located in Cuenca Valle Medio del Magdalena, Colombia; and operates Blocks 16 and 67 oil consortiums located in Ecuador. The company was formerly known as Red Rock Energy Inc. and changed its name to New Stratus Energy Inc. in August 2017. New Stratus Energy Inc. was incorporated in 2005 and is based in Calgary, Canada.Rice Midstream PartnersNYSE:RMPRice Midstream Partners LP owns, operates, develops, and acquires midstream assets in the Appalachian Basin. It operates in two segments, Gathering and Compression, and Water Services. Its natural gas gathering and compression assets consist of natural gas gathering and compression systems that serve producers in the dry gas core of the Marcellus Shale in southwestern Pennsylvania. The company also provides water services to support well completion activities, as well as to collect and recycle or dispose of flowback and produced water in Washington and Greene counties, Pennsylvania; and Belmont County, Ohio. Rice Midstream Management LLC serves as the general partner of Rice Midstream Partners LP. The company was founded in 2014 and is headquartered in Pittsburgh, Pennsylvania.Resolute ResourcesCVE:RRLResolute Resources Ltd., an energy company, engages in the exploration and development of crude oil from shallow cretaceous sandstone reservoirs utilizing multi-lateral drilling technology in Northeast British Columbia and Northwest Alberta. The company was incorporated in 2019 and is based in Calgary, Canada. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.